Maricann Group, Inc. Stock (OTC: MRRCF) (CSE: MARI) - Investor Dashboard
|Employees:||68 as of 12/31/17|
Maricann Group, Inc. – Executive Team
Benjamin Ward – CEO
Ben leads all facets of the company’s management and operations, including its strategic direction and execution, finance and industry relations. He brings extensive domestic and global experience in business development, infrastructure development and capital markets to his leadership of Maricann. Ben holds a BA (Honors) and an MBA from Bradford University School of Management (England), the latter with a dual concentration in Operations and Finance.
Terry Fretz – President
A long-time pharmaceutical executive, Terry was integral in establishing and running two privately held generic pharmaceutical companies. Under his leadership, both organizations were recognized as the fastest growing pharma companies in Canada. Both companies were subsequently acquired by publicly traded multinationals. Terry served as President and General Manager of Watson Pharmaceuticals – Canada before assuming his responsibilities as President at Maricann.
Scott Langille – CFO
Mr. Langille has over 30 years of experience in the pharmaceutical industry in both Canada and the United States. He was formerly Chief Financial Officer of Tribute Pharmaceuticals Canada Inc. (“Tribute Pharmaceuticals”), which was sold to Pozen Inc. in February 2016 for US$160 million to form Aralez Pharmaceuticals Inc. Mr. Langille also served as Chief Financial Officer of Virexx Medical Corp., a biotechnology company, Director, Corporate Finance at Biovail Corporation, Director of Finance at Biovail Pharmaceuticals Canada, Biovail’s sales and marketing division in Canada, as well as Vice President at Biovail Pharmaceuticals Inc., Biovail’s sales and marketing division in the United States. Other prior management positions include Director, Finance at AltiMed Pharmaceuticals Company and Controller at Zimmer Canada. Mr. Langille has a professional accounting designation and an MBA from the University of Toronto.
Significant Insider Ownership
Ben Ward, CEO
Julian Tabatznik, Chairman
Raymond Stone, Director
Eric Silver, Director
Jeremy Blumer, CFO
>10% of voting Rights
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Maricann Group, Inc. is a client of NCV Media, LLC. Read our full disclaimer.